| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haematological malignancies v0.0 | HAVCR2 |
Bryony Thompson gene: HAVCR2 was added gene: HAVCR2 was added to Haematological malignancies cancer susceptibility. Sources: Literature,Expert Review,Expert Review Amber,Expert list Mode of inheritance for gene: HAVCR2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: HAVCR2 were set to 30792187; 32005988; 30374066; 32285995 Phenotypes for gene: HAVCR2 were set to subcutaneous panniculitis-like T-cell lymphoma, MONDO:0019475; T-cell lymphoma, subcutaneous panniculitis-like, OMIM:618398 Mode of pathogenicity for gene: HAVCR2 was set to Other |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||